Indaptus Therapeutics Inc (INDP : NASDAQ)
Common Stock
$2.85
USD
+0.64 (28.96%)
Last updated: 2026-10-15
Follow INDP
INDP
Indaptus Therapeutics Inc
WealthAwesomePerformance
1 Day
+28.96%
1 Week
+20.25%
1 Month
-21.70%
YTD
-36.67%
Key Statistics
Market Cap
$294.47M
52W High
$5.96
52W Low
$0.92
P/E Ratio
-
50 Day MA
$2.06
200 Day MA
$2.28
Beta
0.97
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/15/2026 | $2.25 | $2.89 | $2.25 | $2.85 | $2.85 | 1,311,250 |
| 10/14/2026 | $2.34 | $2.40 | $2.02 | $2.21 | $2.21 | 450,022 |
| 10/13/2026 | $2.44 | $2.52 | $2.35 | $2.39 | $2.39 | 119,358 |
| 10/12/2026 | $2.50 | $2.71 | $2.40 | $2.44 | $2.44 | 363,242 |
| 10/9/2026 | $2.35 | $2.63 | $2.35 | $2.51 | $2.51 | 467,600 |
| 10/8/2026 | $2.37 | $2.53 | $2.29 | $2.37 | $2.37 | 505,428 |
| 10/7/2026 | $2.57 | $2.57 | $2.23 | $2.26 | $2.26 | 589,086 |
| 10/6/2026 | $2.51 | $2.61 | $2.40 | $2.59 | $2.59 | 279,290 |
| 10/5/2026 | $2.35 | $2.53 | $2.25 | $2.51 | $2.51 | 359,466 |
| 10/2/2026 | $2.11 | $2.42 | $1.94 | $2.38 | $2.38 | 568,100 |
Analyst Price Targets
Based on analyst covering INDP · as of Oct 5, 2026
Wall Street analysts forecast INDP stock price to rise 250.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
US$10.00
+250.9% Upside
Current Price
US$2.85
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on INDP's historical volatility
30-Day Vol
226.7%
Annualized
90-Day Vol
183.2%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$3.41
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$3.02 | US$1.38 – US$6.61 |
| 60 trading days | US$3.21 | US$1.06 – US$9.70 |
| 90 trading days | US$3.41 | US$0.88 – US$13.21 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Indaptus Therapeutics Inc
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-19.83M
- Profit Margin
- 0.00%
- ROE (TTM)
- -318.04%
- EPS (Diluted)
- -5.69
- Book Value
- 0.09
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About INDP.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| KNDI | Kandi Technologies Group Inc | $4.11 | +928.50% |
| ESLA | Estrella Immunopharma Inc. | $0.54 | +68.35% |
| SDST | Stardust Power Inc. | $0.04 | +55.38% |
| XLAB | Exascale Labs Holdings Inc. Class A Common Stock | $1.36 | +49.70% |
| WETO | Webus International Limited Ordinary Shares | $1.22 | +46.88% |
| RITRF | Reitar Logtech Holdings Limited | $0.02 | +40.85% |
| DRMA | Dermata Therapeutics Inc | $0.91 | +37.19% |
| LESLQ | Leslie's, Inc. | $0.03 | +35.75% |